Asianet Newsable on MSN
Biogen stock to pop again? China fast-tracks at-home Alzheimer’s drug Leqembi
Analyst price targets for BIIB are in the range of $190 to $215, implying a downside of about 6% to an upside of nearly 7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results